Evidence map›Paper›PMID 22239607›Full record

ArticleFEMS microbiology letters2012

A novel membrane-bound toxin for cell division, CptA (YgfX), inhibits polymerization of cytoskeleton proteins, FtsZ and MreB, in Escherichia coli.

Hisako Masuda, Qian Tan, Naoki Awano, Yoshihiro Yamaguchi, Masayori Inouye

Open access · greenAbstract read
In one paragraph

Article in FEMS microbiology letters, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 64 citations in OpenAlex.

  1. KilR ofmSphere · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hisako MasudaDepartment of Biochemistry, Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Qian Tan
Naoki Awano
Yoshihiro Yamaguchi
Masayori Inouye
Tokyo Medical University · JP

Funding

Deciphering of the Toxin-Antitoxin Systems in E. coliR01GM081567 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI INOUYE, MASAYORI · 2009 to 2012
$1.8M
Characterization of new toxins (YmgD and YdfD) from E.coli, targeting cell wallF32GM095200 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI MASUDA, HISAKO · 2011 to 2012
$105k
NIGMS NIH HHS F32 GM095200NIGMS NIH HHS F32GM095200NIGMS NIH HHS R01 GM081567NIGMS NIH HHS R01GM081567
6 · The paper itself

Abstract

Nearly all free-living bacteria carry toxin-antitoxin (TA) systems on their genomes, through which cell growth and death are regulated. Toxins target a variety of essential cellular functions, including DNA replication, translation, and cell division. Here, we identified a novel toxin, YgfX, on the Escherichia coli genome. The toxin, consisting of 135 residues, is composed of the N-terminal membrane domain, which encompasses two transmembrane segments, and the C-terminal cytoplasmic domain. Upon YgfX expression, the cells were initially elongated and then the middle portion of the cells became inflated to form a lemon shape. YgfX was found to interact with MreB and FtsZ, two essential cytoskeletal proteins in E. coli. The cytoplasmic domain [YgfX(C)] was found to be responsible for the YgfX toxicity, as purified YgfX(C) was found to block the polymerization of FtsZ and MreB in vitro. YgfY, located immediately upstream of YgfX, was shown to be the cognate antitoxin; notably, YgfX is the first membrane-associating toxin in bacterial TA systems. We propose to rename the toxin and the antitoxin as CptA and CptB (for Cytoskeleton Polymerization inhibiting Toxin), respectively.

Indexed as

Bacterial ProteinsBacterial ToxinsCell DivisionCell MembraneCytoplasmCytoskeletal ProteinsEndopeptidasesEscherichia coliEscherichia coli ProteinsGenome, BacterialGrowth InhibitorsPlasmidsProtein Interaction MappingProtein MultimerizationProtein Structure, TertiaryTranscription FactorsBacterial ProteinsBacterial ToxinsCptA protein, bacteriaCytoskeletal ProteinsEndopeptidasesEscherichia coli ProteinsFtsZ protein, BacteriaGrowth InhibitorsMreB protein, E coliTranscription FactorsYgfY protein, E coli

Identifiers

PMID22239607
PMCPMC3334289
OpenAlexW2126405079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.